Curated News:

Osteoarthritis affects 240 million people worldwide and is one of the most common causes of disability in both humans and animals. Currently, no therapeutics exist to prevent this disease, but recent multidisciplinary research at Cornell reveals that the application of a proprietary peptide known as SS-31 may protect cartilage from the injury that leads to arthritis.

Channels: All Journal News, Pharmaceuticals, National Institutes of Health (NIH),

Keywords: Osteoarthritis

It would be the first treatment for "dry" age-related macular degeneration and could significantly improve treatment for wet AMD.

Channels: Aging, Healthcare, Seniors, Vision, National Institutes of Health (NIH), PNAS, All Journal News, Grant Funded News,

Keywords: Macular Degeneration, AMD, Wet Amd, Dry Amd, dry macular degeneration, Wet Macular Degeneration, Ophthalmology, ophthalmalogic treatment, Eye Disease, Blindness, Blinding, Blind, Aging, Elderly, ophthalmology research, Medical Research, UVA, University Of Virginia, University of Virginia School of Medicine, UVA School of Medicine, UVA School of Engineering, En

As controversy swirls around the vaping industry, a team of Cornell researchers has set out to help regulators identify the most effective health warnings to include in advertisements for electronic cigarettes.

Channels: Children's Health, Government/Law, Public Health, Smoking, Technology, National Cancer Institute (NCI), National Institutes of Health (NIH), All Journal News,

Overweight and obese vitamin D-deficient children who took a relatively high dose of vitamin D every day for six months had lower blood pressure and improved insulin sensitivity than their peers who took a lower dose, according to the results of a new clinical trial.

Channels: Cardiovascular Health, Children's Health, Clinical Trials, Diabetes, Obesity, Pharmaceuticals, National Institutes of Health (NIH), All Journal News, Grant Funded News,

Keywords: Vitamin D, Pediatric, Cardiovascular

A variety of existing drugs for treating conditions such as diabetes, inflammation, alcohol abuse, and arthritis in dogs can also kill cancer cells in the lab, according to a study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

Channels: All Journal News, Grant Funded News, Cancer, Clinical Trials, Pharmaceuticals, National Institutes of Health (NIH), Nature (journal), Cancer Center Featured Story 2, Embargoed Feed - hidden,

Keywords: Dana-Farber Cancer Institute, Dana-Farber, Broad Institute of MIT and Harvard, drug repurposing

Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance.

Channels: Clinical Trials, Liver Disease, Obesity, Pharmaceuticals, Weight Loss, National Institutes of Health (NIH), Grant Funded News,

Keywords: Nash, Liver Cancer

The lungs and placentas of fetuses in the womb — as young as 11 weeks after conception — already show a bacterial microbiome signature, which suggests that bacteria may colonize the lungs well before birth. How the microbes or microbial products reach those organs before birth is not known.

Channels: All Journal News, Immunology, Microbiome, OBGYN, National Institutes of Health (NIH), Staff Picks,

Keywords: Fetal Development, fetal lung development, Microbiome, lung microbiome, Premature Babies, Bronchopulmonary Dysplasia (Bpd)

A woman's supply of eggs is finite, so it is crucial that the quality of their genetic material is ensured.

Channels: Cell Biology, Genetics, OBGYN, Women's Health, National Institutes of Health (NIH), Nature (journal), All Journal News,

Keywords: Developmental Biology, Reproductive Biology, Fertility, Physiology, Molecular Biology

When University of California, Irvine neurobiologist Carey Y.L. Huh, Ph.D., set her sights on discovering more about amblyopia, she brought personal insight to her quest. As a child, Huh was diagnosed with the condition, which is often called “lazy eye.” he and her colleagues have just found that amblyopia originates in an earlier stage of the visual pathway than was previously thought. Their research, which raises the possibility of new treatment approaches, appears in the Journal of Neuroscience.

Channels: Pharmaceuticals, Vision, National Institutes of Health (NIH), Children's Health, Healthcare, All Journal News, Staff Picks,

Keywords: Neurobiology, Vision, lazy eye treatment